BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September

Day

• 1
• 2
• 3
• 4

• Press Releases

  Corvus Pharmaceuticals to Present at the 2026 Cantor Global Healthcare Conference

  September 3, 2026

   · 

  1 min read
• Press Releases

  Nexalin Technology Announces New Secondary Analysis of Previously Published Clinical Trial Data Reveals Previously Unreported Improvements in Memory, Comprehension and Language Function in Alzheimer’s Patients; ADAS-Cog Subscale Analysis to Guide Design of Planned U.S. Alzheimer’s Pilot Study

  September 3, 2026

   · 

  11 min read
• Press Releases

  Bicara Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - September 3, 2026

  September 3, 2026

   · 

  2 min read
• Press Releases

  Bone Biologics to Participate in the H.C. Wainwright 28th Annual Global Investment Conference

  September 3, 2026

   · 

  1 min read
• Press Releases

  Adneuris Therapeutics to Present at PAINWeek 2026

  September 3, 2026

   · 

  5 min read
• Press Releases

  Kala Bio and Virotek Finalize Definitive Agreement Establishing Exclusive U.S. Distribution Partnership for Ophthalmology Genetic Testing Program

  September 3, 2026

   · 

  8 min read
• Press Releases

  Citius Pharmaceuticals to Participate in September 2026 Investor Conferences

  September 3, 2026

   · 

  3 min read
• Press Releases

  AbbVie Completes Acquisition of Apogee Therapeutics

  September 3, 2026

   · 

  8 min read
• Press Releases

  FibroBiologics Announces Issuance of New U.S. Patent for the Therapeutic Use of Fibroblasts in Wound Healing

  September 3, 2026

   · 

  5 min read
• 

  Lung cancer

  Summit, Akeso’s ivonescimab bests Merck’s Keytruda in China trial—again

  New Phase 3 data show that Summit Therapeutics and Akeso’s PD-1/VEGF therapy improved overall survival in patients with a type of lung cancer as compared to Merck’s Keytruda but the results will need to be replicated in non-Chinese patients.

  September 3, 2026

   · 

  2 min read

   · 

  Annalee Armstrong